Last reviewed · How we verify

NCT07027007: DIVENDO

Prospective Observational Analysis of Circulating Endocan Levels in Patients Presenting With Acute Diverticulitis

Not yet recruiting Last updated 10 June 2025
What this trial tests

trial in Diverticulitis in 60 participants. Not yet recruiting.

Timeline
30 September 2025
Primary endpoint
1 September 2026
1 September 2027

Quick facts

Lead sponsorIRCCS Ospedale San Raffaele
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment60
Start date30 September 2025
Primary completion1 September 2026
Estimated completion1 September 2027
Sites1 location across Italy

Conditions studied

Sponsor

IRCCS Ospedale San Raffaele — full company profile →

Who can join

Adults 18 to 80, any sex, with Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Quantify the level of endocan in blood samples collected from patients with acute diverticulitis in the emergency department. Determine if endocan levels are correlated with the severity of diverticulitis according to the WSES classification. Assess whether patients requiring emergency surgical intervention have higher endocan values compared to others.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diverticulitis

Currently open trials in the same condition.

Other IRCCS Ospedale San Raffaele trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07027007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing